DMKJ
FSTX

David M. Knott Jr’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

David M. Knott Jr’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-235,945
Closed -$1.21M – 190
2022
Q3 		$1.21M Buy
235,945
+160,491
+213% +$1.01M 0.51% 43
2022
Q2 		$472K Buy
+75,454
New +$254K 0.2% 68

Other funds holding FSTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

David M. Knott Jr's FSTX Position: Q4 2022 in Review

David M. Knott Jr sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2022, closing a stake of 235,945 shares — an estimated $1.21M sold.

David M. Knott Jr first reported a position in FSTX in Q2 2022 and held it in 2 quarters. The position peaked at $1.21M in Q3 2022. 59 funds tracked by Wall St. Rank hold FSTX as of Q4 2022.

  • David M. Knott Jr reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • David M. Knott Jr sold 235,945 F-star Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.21M.
  • David M. Knott Jr first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • David M. Knott Jr's F-star Therapeutics, Inc. Common Stock position peaked at $1.21M in Q3 2022.
  • 59 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2022.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.